Cenavisa

Cenavisa, established in 1965, is an European veterinary pharmaceutical laboratory renowned for its extensive expertise in developing, manufacturing, and marketing high-quality veterinary products. With a deep-rooted commitment to excellence, Cenavisa specializes in a broad spectrum of solutions, including antimicrobial, antiparasitic, and anti-inflammatory medicines, along with biocides and nutritional products tailored for diverse animal species. Headquartered in Spain and authorized by the Spanish Agency of Medicines (AEMPS), Cenavisa adheres to the most stringent European regulations, evidenced by its GMP certification for Good Manufacturing Practices. This certification underscores the company’s dedication to maintaining superior standards of product quality and safety. Over the decades, Cenavisa has expanded its reach well beyond Spain, establishing a strong global presence in over 60 countries across five continents. This international footprint is bolstered by strategic partnerships with a network of distributors, which facilitates effective market expansion and global product delivery. With a legacy of quality and a forward-looking approach, Cenavisa is dedicated to advancing the standards of animal health and welfare worldwide, driving progress in the veterinary pharmaceutical industry through both product excellence and global expansion.